2023
Elevated C-reactive protein mediates the liver-brain axis: a preliminary study
Jiang R, Wu J, Rosenblatt M, Dai W, Rodriguez R, Sui J, Qi S, Liang Q, Xu B, Meng Q, Calhoun V, Scheinost D. Elevated C-reactive protein mediates the liver-brain axis: a preliminary study. EBioMedicine 2023, 93: 104679. PMID: 37356206, PMCID: PMC10320521, DOI: 10.1016/j.ebiom.2023.104679.Peer-Reviewed Original ResearchConceptsRegional gray matter volumeGray matter volumeCognitive functioningMost cognitive measuresUnderlying neurobiological factorsEffect sizeLarge effect sizesProspective memoryVisual memoryCognitive measuresExecutive functionTrail MakingCognitive performanceNeurobiological factorsSmall effect sizesProcessing speedVentral striatumParahippocampal gyrusCognitive declineCognitive impairmentMatter volumeMemoryFunctioningCross-sectional associationsLimited research
2022
Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease
Hajjar I, Okafor M, Wan L, Yang Z, Nye J, Bohsali A, Shaw L, Levey A, Lah J, Calhoun V, Moore R, Goldstein F. Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease. Brain Communications 2022, 4: fcac270. PMID: 36440097, PMCID: PMC9683395, DOI: 10.1093/braincomms/fcac270.Peer-Reviewed Original ResearchProdromal Alzheimer's diseaseMild cognitive impairmentCognitive effectsCognitive functionCognitive impairmentNon-hypertensive individualsAlzheimer's diseasePositive cognitive effectsAssociated with improved executive functionComposite cognitive scoreGlobal cognitive functionFunctional network connectivityImproving global cognitive functionBrain amyloid accumulationExecutive functionExploratory outcomesCognitive measuresSubcortical networksHippocampal volumeNon-hypertensive adultsFalse discovery rate correctionParahippocampal regionIntention-to-treat approachPlacebo-controlled trialNon-hypertensive participants